FI874628A - Foerfarande foer framstaellning av bindemedelfritt tabletteringsdugligt celiprololhydrokloridgranulat. - Google Patents

Foerfarande foer framstaellning av bindemedelfritt tabletteringsdugligt celiprololhydrokloridgranulat. Download PDF

Info

Publication number
FI874628A
FI874628A FI874628A FI874628A FI874628A FI 874628 A FI874628 A FI 874628A FI 874628 A FI874628 A FI 874628A FI 874628 A FI874628 A FI 874628A FI 874628 A FI874628 A FI 874628A
Authority
FI
Finland
Prior art keywords
particle size
fluidized bed
granules
tabletteringsdugligt
celiprololhydrokloridgranulat
Prior art date
Application number
FI874628A
Other languages
English (en)
Other versions
FI874628A0 (fi
FI86375B (fi
FI86375C (fi
Inventor
Heinrich Schluenken
Original Assignee
Chemie Linz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemie Linz Ag filed Critical Chemie Linz Ag
Publication of FI874628A0 publication Critical patent/FI874628A0/fi
Publication of FI874628A publication Critical patent/FI874628A/fi
Publication of FI86375B publication Critical patent/FI86375B/fi
Application granted granted Critical
Publication of FI86375C publication Critical patent/FI86375C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI874628A 1986-10-24 1987-10-21 Foerfarande foer framstaellning av bindemedelfritt tabletteringsdugligt celiprololhydrokloridgranulat. FI86375C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3636209 1986-10-24
DE19863636209 DE3636209A1 (de) 1986-10-24 1986-10-24 Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates

Publications (4)

Publication Number Publication Date
FI874628A0 FI874628A0 (fi) 1987-10-21
FI874628A true FI874628A (fi) 1988-04-25
FI86375B FI86375B (fi) 1992-05-15
FI86375C FI86375C (fi) 1992-08-25

Family

ID=6312393

Family Applications (1)

Application Number Title Priority Date Filing Date
FI874628A FI86375C (fi) 1986-10-24 1987-10-21 Foerfarande foer framstaellning av bindemedelfritt tabletteringsdugligt celiprololhydrokloridgranulat.

Country Status (10)

Country Link
US (1) US4795646A (fi)
EP (1) EP0268813B1 (fi)
JP (1) JPS63112517A (fi)
AT (1) ATE58830T1 (fi)
DE (2) DE3636209A1 (fi)
DK (1) DK557587A (fi)
ES (1) ES2021673B3 (fi)
FI (1) FI86375C (fi)
GR (1) GR3001167T3 (fi)
NO (1) NO174453C (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0423484B1 (de) * 1989-10-16 1993-11-03 PCD-Polymere Gesellschaft m.b.H. Pressling mit retardierter Wirkstofffreisetzung
DE3935736A1 (de) * 1989-10-27 1991-05-02 Chemie Linz Deutschland Pressling mit retardierter wirkstofffreisetzung
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
US20210077479A1 (en) 2017-08-30 2021-03-18 Acadia Pharmaceuticals Inc. Formulations of pimavanserin

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL136037C (fi) * 1965-08-27
JPS4949299B1 (fi) * 1968-09-09 1974-12-26
GB1410588A (en) * 1971-08-10 1975-10-22 Fisons Ltd Composition
US3784708A (en) * 1972-02-28 1974-01-08 Hoffmann La Roche Directly compressible monocalcium phosphate
AT334385B (de) * 1973-12-20 1976-01-10 Chemie Linz Ag Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen
DE2535258C2 (de) * 1974-08-10 1993-06-03 Fisons Plc, Ipswich, Suffolk Inhalierbares Medikament in Pelletform
GB1520247A (en) * 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
DK221879A (da) * 1978-10-02 1980-04-03 Sepywood Lab Ltd Gummi dets fremstilling og anvendelse
JPS5759803A (en) * 1980-09-30 1982-04-10 Takeda Chem Ind Ltd Granule of l-sodium ascorbate, its preparation, and tablet comprising it
AR226763A1 (es) * 1980-12-22 1982-08-13 Monsanto Co Metodo de preparacion de una granulacion analgesica de acetaminofeno
US4439453A (en) * 1980-12-22 1984-03-27 Monsanto Company Directly compressible acetaminophen granulation
US4470965A (en) * 1982-10-27 1984-09-11 Usv Pharmaceutical Corporation Celiprolol for the treatment of glaucoma
DE3410380A1 (de) * 1984-03-21 1985-10-10 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München S(-)-celiprolol, dessen pharmazeutisch vertraegliche salze, verfahren zu dessen herstellung, verwendung in der therapie und pharmazeutische zubereitungen

Also Published As

Publication number Publication date
US4795646A (en) 1989-01-03
NO174453C (no) 1994-05-11
EP0268813B1 (de) 1990-12-05
JPS63112517A (ja) 1988-05-17
DK557587A (da) 1988-04-25
NO174453B (no) 1994-01-31
NO874311D0 (no) 1987-10-15
FI874628A0 (fi) 1987-10-21
DE3636209A1 (de) 1988-04-28
EP0268813A1 (de) 1988-06-01
ATE58830T1 (de) 1990-12-15
DE3766601D1 (de) 1991-01-17
FI86375B (fi) 1992-05-15
GR3001167T3 (en) 1992-06-30
ES2021673B3 (es) 1991-11-16
NO874311L (no) 1988-04-25
FI86375C (fi) 1992-08-25
DK557587D0 (da) 1987-10-23

Similar Documents

Publication Publication Date Title
BR0002932A (pt) Encapsulação de ingredientes ativos
ES551854A0 (es) Procedimiento para la obtencion de un granulado vertible.
SE8603247L (sv) Granulerad form med fordrojd frigoring av farmaceutiskt aktiva substanser
NO872241L (no) Fremgangsmaate ved granulering av vannopploeselig gjoedsel med hoeyt kieserittinnhold.
FI874628A (fi) Foerfarande foer framstaellning av bindemedelfritt tabletteringsdugligt celiprololhydrokloridgranulat.
JPS5753403A (en) Composition containing spray dry particle of n-acetyl-p-aminophenol and manufacture
CA1199871A (en) Drug preparations for glycoside hydrolase inhibitors
JPS5726615A (en) Improving method for absorbability of slightly soluble drug
PL261696A1 (en) Method of simultaneously evaporating and granulating extracted substances from calf&#39;s blood
KR927002213A (ko) 유효성분의 과립을 매끈하게 하는 방법
ES8304047A1 (es) &#34;procedimiento para la fabricacion de un substrato granular, especialmente para hidrocultivos&#34;.
BR1100487A (pt) Processo para a preparação de pelotas e medicamentos para a administração oral
SE7700665L (sv) Forfarande for framstellning av en lekemedelskomposition
JPS5684628A (en) Gypsum desiccating agent
DE59000209D1 (de) Feste arzneiform mit hohem verapamil-gehalt.
JPS56113266A (en) Preparation of alpha-starch
JPS5665826A (en) Depressant of allergic reaction
TH40680A (th) กรรมวิธีสำหรับเตรียมซิลิคา
RU99112300A (ru) Способ получения лечебно-профилактического препарата &#34;винибис-ю&#34; и устройство для осуществления способа
TH26267B (th) รูปเป็นผงของโคลีนคลอไรด์กรรมวิธีผลิตสิ่งนั้นและการใช้ของสิ่งเหล่านั้นในอาหารสัตว์
JPS5576893A (en) Novel antitumorigenic substance, its preparation and antitumorigenic agent containing the same as the effective component

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: HAFSLUND NYCOMED PHARMA